Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to...
Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky Minerals (LKMNF).
Bonafide Gold Rush in Ecuador as the World’s Biggest Miners Race to Stake Claims in the Largest Land Grab in Gold...
Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.
- Rule 506(c) Offering Solely to Accredited Investors -
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Redefy Corporation* (a/k/a...
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon.
June 13,...
Circle Group Holdings (CRGQ) $0.47 Report.
Click to Download.
Client, we were compensated with 100,000 shares and warrants to purchase...
Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.
Download Circle Group - Z-Trim Report
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
HCN Navigator Driving ‘Profit at First Touch’ for Hotels.
With more than 80 percent of guests using HCN interactive tablets daily, hoteliers are increasing revenues from onsite services sales and digital...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
